Hammada scoparia flavonoids and rutin kill adherent and chemoresistant leukemic cells

Leukemia Research

Volumn 35, Issue 8, 2011, Pages 1093-1101

  Bourogaa, Ezzeddine ^c   Bertrand, Jessica ^a   Despeaux, Mathieu ^a   Jarraya, Raoudha ^c   Fabre, Nicolas ^e   Payrastre, Laurence ^f   Demur, Cécile ^a,b   Fournié, Jean Jacques ^a   Damak, Mohamed ^c   Feki, Abdelfattah El ^d   Racaud Sultan, Claire ^a  

^a INSERM   (France)

^b CHU PURPAN   (France)

^c Laboratoire de Chimie des Substances Naturelles   (Tunisia)

^d Laboratoire d'Ecophysiologie Animale   (Tunisia)

^e UNIVERSITÉ DE TOULOUSE   (France)

^f UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Cell adhesion; Drug resistance; Flavonoids; GSK3 ; Leukemia

Indexed keywords

ANTILEUKEMIC AGENT; CD123 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; FLAVONOID; FLAVONOID GLYCOSIDE; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR; HAMMADA SCOPARIA EXTRACT; ISORHAMNETIN GLYCOSIDE; ISORHAMNETIN XYLOSE GALACTOSE; PLANT EXTRACT; QUERCETIN XYLOSE RHAMNOSE GALACTOSE; QUERCETOL GLYCOSIDE; RUTOSIDE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CELL ADHESION; CELL STRAIN HL 60; CELL STRAIN KG1; CELL STRAIN KG1A; CELL STRAIN U937; CELL SURVIVAL; CELL SUSPENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; ENZYME INHIBITION; ENZYME REGULATION; HAMMADA SCOPARIA; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIQUID CHROMATOGRAPHY; MEDICINAL PLANT; PLANT LEAF; PRIORITY JOURNAL; SURVIVAL RATE; TANDEM MASS SPECTROMETRY;

ANTIGENS, CD34; APOPTOSIS; BLOTTING, WESTERN; CELL ADHESION; CELLS, CULTURED; DRUG RESISTANCE, NEOPLASM; FLAVONOIDS; FLOW CYTOMETRY; GLYCOGEN SYNTHASE KINASE 3; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, ACUTE; PHYTOTHERAPY; RUTIN; SCOPARIA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79960227050     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.12.011     Document Type: Article

References (31)

1. Ishikawa F., Yoshida S., Saito Y., Hijikata A., Kitamura H., Tanaka S., et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nature Biotechnology 2007, 25:1315-1321.
2. De Toni F., Racaud-Sultan C., Chicanne G., Mas V.M., Cariven C., Mesange F., et al. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 2006, 25:3113-3122.
3. Guzman M.L., Rossi R.M., Karnischky L., Li X., Peterson D.R., Howard D.S., et al. The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells. Blood 2005, 105:4163-4169.
4. Xu Q., Thompson J.E., Carroll M. mTOR regulates cell survival after etoposide treatment in primary AML cells. Blood 2005, 106:4261-4268.
5. Matsunaga T., Takemoto N., Sato T., Takimoto R., Tanaka I., Fujimi A., et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nature Medicine 2003, 9:1158-1165.
6. Hoeflich K.P., Luo J., Rubie E.A., Tsao M.S., Jin O., Woodgett J.R. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 2000, 406:86-90.
7. Steinbrecher K.A., Wilson W., Cogswell P.C., Baldwin A.S. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription. Molecular and Cellular Biology 2005, 25:8444-8455.
8. 1 integrin-dependent survival pathway through GSK3β activation in leukemic cells. PLoS One 2010, 5:e9807.
9. Ben Salah H., Jarraya R., Martin M.T., Veitch N.C., Grayer R.J., Simmonds M.S., et al. Flavonol triglycosides from the leaves of Hammada scoparia (POMEL) ILJIN. Chemical & Pharmaceutical Bulletin (Tokyo) 2002, 50:1268-1270.
10. Benkrief R., Brum-Bousquet M., Tillequin F., Koch M. Alkaloids and flavonoid from aerial parts of Hammada articulata ssp. scoparia. Annales Pharmaceutiques Françaises 1990, 48:219-224.
11. El-Shazly A., Wink M. Tetrahydroisoquinoline and beta-carboline alkaloids from Haloxylon articulatum (Cav.) Bunge (Chenopodiaceae). Zeitschrift Fur Naturforschung C-a Journal of Biosciences 2003, 58:477-480.
12. Hvattum E., Ekeberg D. Study of the collision-induced radical cleavage of flavonol glycosides using negative electrospray ionization tandem quadrupole mass spectrometry. Journal of Mass Spectrometry 2003, 38:43-49.
13. Fabre N., Rustan I., de Hoffmann E., Quetin-Leclercq J. Determination of flavone, flavonol, and flavanone aglycones by negative ion liquid chromatography electrospray ion trap mass spectrometry. Journal of the American Society for Mass Spectrometry 2001, 12:707-715.
14. Ferreres F, Llorach R., Gil-Izquierdo A. Characterization of the interglycosidic linkage in di-, tri-, tetra- and pentaglycosylated flavonoids and differentiation of positional isomers by liquid chromatography/electrospray ionization tandem mass spectrometry. Journal of Mass Spectrometry 2004, 39:312-321.
15. Kops G.J., Dansen T.B., Polderman P.E., Saarloos I., Wirtz K.W., Coffer P.J., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419:316-321.
16. Misaghian N., Ligresti G., Steelman L.S., Bertrand F.E., Bäsecke J., Libra M., et al. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. Leukemia 2009, 23:25-42.
17. Karp J.E., Passaniti A., Gojo I., Kaufmann S., Bible K., Garimella T.S., et al. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-d-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias. Clinical Cancer Research 2005, 11:8403-8412.
18. Karp J.E., Smith B.D., Levis M.J., Gore S.D., Greer J., Hattenburg C., et al. Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia. Clinical Cancer Research 2007, 13:4467-4473.
19. Byrd J.C., Lin T.S., Dalton J.T., Wu D., Phelps M.A., Fischer B., et al. Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia. Blood 2007, 109:399-404.
20. Blum W., Phelps M.A., Klisovic R.B., Rozewski D.M., Ni W., Albanese K.A., et al. Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias. Haematologica 2010, 95:1098-1105.
21. Jeong J.J., Ha Y.M., Jin Y.C., Lee E.J., Kim J.S., Kim H.J., et al. Rutin from Lonicera japonica inhibits myocardial ischemia/reperfusion-induced apoptosis in vivo and protects H9c2 cells against hydrogen peroxide-mediated injury via ERK1/2 and PI3K/Akt signals in vitro. Food and Chemical Toxicology 2009, 47:1569-1576.
22. Litovchick L., Chestukhin A., DeCaprio J.A. Glycogen synthase kinase 3 phosphorylates RBL2/p130 during quiescence. Molecular and Cellular Biology 2004, 24:8970-8980.
23. Kotliarova S., Pastorino S., Kovell L.C., Kotliarov Y., Song H., Zhang W., et al. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Research 2008, 68:6643-6651.
24. Sheu M.L., Ho F.M., Yang R.S., Chao K.F., Lin W.W., Lin-Shiau S.Y., et al. High glucose induces human endothelial cell apoptosis through a phosphoinositide 3-kinase-regulated cyclooxygenase-2 pathway. Arteriosclerosis Thrombosis and Vascular Biology 2005, 25:539-545.
25. Kim C.H., Ko A.R., Lee S.Y., Jeon H.M., Kim S.M., Park H.G., et al. Hypoxia switches glucose depletion-induced necrosis to phosphoinositide 3-kinase/Akt-dependent apoptosis in A549 lung adenocarcinoma cells. International Journal of Oncology 2010, 36:117-124.
26. Saito Y., Uchida N., Tanaka S., Suzuki N., Tomizawa-Murasawa M., Sone A., et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nature Biotechnology 2010, 28:275-280.
27. Casagrande F., Darbon J.M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochemical Pharmacology 2001, 61:1205-1215.
28. Rizzolio F., Tuccinardi T., Caligiuri I., Lucchetti C., Giordano A. CDK inhibitors: from the bench to clinical trials. Current Drug Targets 2010, 11:279-290.
29. Nadova S., Miadokova E., Cipak L. Flavonoids potentiate the efficacy of cytarabine through modulation of drug-induced apoptosis. Neoplasma 2007, 54:202-206.
30. Karp J.E., Blackford A., Smith B.D., Alino K., Seung A.H., Bolaños-Meade J., et al. Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia. Leukemia Research 2010, 34:877-882.
31. Lin J.P., Yang J.S., Lu C.C., Chiang J.H., Wu C.L., Lin J.J., et al. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leukemia Research 2009, 33:823-828.